Skip to content

InsiderTradesSIGMA

RecommendationsTOP BasketNEW TerminalNEW

Companies Executives Performance Blog

InsidersTradesSigma

InsiderTradesSIGMA

Multi-market insider intelligence. Official public filings, re-aggregated and scored. Private beta.

FR US DE CH GB CA IT ES NL BE NO FI DK AU AT IE KR IN JP HK+ 8 markets

Recommendations
Terminal
Companies
Insiders
Performance
Backtest
Compare

Markets
Sectors
Top movers
Leaderboard
Clusters
Heatmap
Archive
Insider buying this week
Cluster signals

Methodology
How it works
Glossary
API docs
Status
Blog

Sign in
Create account
Portfolio
API keys
Alerts
Upgrade

Privacy
Terms
Cookies
Contact
About

Built in Paris. Public sources across 43 markets: AMF France, SEC EDGAR Form 4 US, BaFin Germany, SIX SER Switzerland, RNS United Kingdom, SEDI Canada, Consob Italy, CNMV Spain, AFM Netherlands, FSMA Belgium, Oslo Bors Norway, Nasdaq Helsinki, Nasdaq Copenhagen, ASX Australia, FMA Austria, CVM Brazil, HKEX Hong Kong, BSE-Sofia Bulgaria, Tadawul Saudi Arabia, DART South Korea, EDINET Japan, SSE and SZSE China, SEBI India, KNF Poland, PSE Philippines, NZX New Zealand, JSE South Africa, among others. Prices + fundamentals via Yahoo Finance, STOXX 600 sector ETFs (iShares Xetra). Stack: Next.js 16, Prisma, Vercel. Live out-of-sample tracker since 2026-05-16. Methodology audits: /methodologie and /docs/method-review/.

Sources: official public filings under MAR Art.19 (EU and EEA), SEC Section 16 / Form 4 (US), Art.56 SESTA (CH, SIX SER), NI 55-104 / SEDI (CA), Corporations Act s205G (AU) and equivalent regimes. Signals on this site are for educational use only and do not constitute investment advice within the meaning of MiFID II / SEC Reg-IA. Past performance does not guarantee future results. Swiss SIX SER filings are anonymised by law (role only, no name).

© 2026 Insiders TradesΣ·Private beta·Hosted on Vercel

Built bySimon Azoulay

All systems operational

Companies · Healthcare & Pharma · InsiderTrades Sigma · page 22

Sector3,940

Healthcare & Pharma

Gain Therapeutics, Inc.

Galderma Group AG

Galectin Therapeutics INC

Galera Therapeutics, Inc.

Gamida Cell Ltd.

Garofalo Health Care

Garofalo Health Care GHC Acquisisce LO Storico Gruppo Romano da CUI HA Tratto le SUE Origini / GHC Acquires the Historical Roman Group From Which IT Drew ITS Origins

Garofalo Health Care Garofalo Health Care S.P.A. Acquisisce Casa di Cura Citta’ di Roma / Garofalo Health Care S.P.A. Acquires Casa di Cura Citta' di Roma

Garofalo Health Care Garofalo Health Care S.p.a.: Assemblea Ordinaria e Straordinaria degli Azionisti / Ordinary and Extraordinary Shareholders' Meeting

Garofalo Health Care Garofalo Health Care S.p.a.: Standard Ethics Alza IL Rating di Sostenibilita' / Standard Ethics Raises Sustainability Rating

Garofalo Health Care Garofalo Health Care S.p.a.: Standard Ethics Conferma IL Rating ESG di Breve e Medio/lungo Termine / Standard Ethics Confirms Short-Term and Medium/long-Term ESG Ratings

Garofalo Health Care SPA

Gelesis Holdings, INC.

Gemini Therapeutics, Inc. /DE

Gemini Therapeutics, Inc. /DE

GeneDx Holdings Corp.

Generation Bio Co.

Genesis Healthcare, Inc.

Genky DrugStores株式会社

Genocea Biosciences, INC.

Gens Global株式会社

Genscript Biotech Corporation

Gentian Diagnostics ASA

Genufood Energy Enzymes Corp.

GeoVax Labs, Inc.

Gerresheimer AG

Gilead Sciences INC

Gilead Sciences, INC.

Ginkgo Bioworks Holdings, Inc.

Gland Pharma Limited

Glenmark Pharmaceuticals Limited

Global Blood Therapeutics, Inc.

Global Cosmed S.A.

Globus Medical INC

Glycomimetics INC

Good Fellow Healthcare Holdings Ltd.

GoodRx Holdings, Inc.

Gossamer Bio, Inc.

Grand Pharmaceutical Group Ltd.

Previous 1...10 20 212223 24...30 40 50 60...79 Next